Searched for
DRUG CANDIDATES GENERATION
US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Global firms rethink GCC hiring in India as AI shifts skill demandGlobal firms in India are hiring cautiously. Artificial intelligence is changing job roles, making it harder to find talent with advanced t...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Soleno shares jump 33% as Neurocrine expands into metabolic diseases with $2.9 billion buyoutNeurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, mark...
- Unconventional ways during war and uncertain times: 4 stocks with dividend yield of up to 5.9%A high dividend yield by itself is not a sign of safety. Sometimes, a stock yields more only because the price has collapsed for a valid re...
- Piyush Goyal questions Tamil Nadu finances, unveils white paper, attacks DMK over 'family rule'Union Minister Piyush Goyal has sharply criticized the DMK government in Tamil Nadu. He questioned Chief Minister MK Stalin about the state...
- Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growthHyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. T...
- IIT Madras, Ohio State University develop AI framework to aid drug discoveryIIT Madras and Ohio State University researchers have unveiled PURE, an AI framework that generates drug-like molecules with enhanced lab s...
- AstraZeneca, AI biologics firm Absci tie up on cancer drugAbsci's collaboration with AstraZeneca aims for a zero-shot generative AI model designed to create new and improved antibody therapeutics
- Daiichi Sankyo, Merck ink $22-billion cancer drug dealThe deal adds promising drug candidates to Merck's oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expir...
- New drug decreases the growth of tumour cells in breast cancerThis is the first example of taking a genetic sequence and designing a drug candidate that works effectively.
- New malaria vaccine generates robust immune responseA new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...
- Ruling SAD-BJP failed to eliminate drug meance: Yogendra YadavSenior Aam Aadmi Party leader Yogendra Yadav today accused SAD-BJP govt of failing to protect youth from drugs and allowing sand mafia to f...
- Jubilant Biosys inks drug discovery pact with Mnemosyne PharmaJubilant Biosys today said it has entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc.
- Zydus files IND application with DCGI for diabetes and obesityHealthcare major, Zydus Cadila has filed IND (Investigational New Drug) application for anti-diabetic and anti-obesity drug with Drugs Cont...
Load More
